Your browser doesn't support javascript.
loading
Looking to the future after reintroduction of clozapine.
Muñoz-Manchado, Leticia I; Villagrán-Moreno, Jose María; Palacios-Garrán, Roberto; Pérez-Revuelta, Jose Ildefonso.
Afiliación
  • Muñoz-Manchado LI; UGC North of Cadiz, Mental Health Inpatient Unit, General Hospital, Jerez de la Frontera, Spain; Serious Mental Disorder Research Group, Cadiz Biomedical Research and Innovation Institute, Spain. Electronic address: leticiamm94@hotmail.com.
  • Villagrán-Moreno JM; UGC North of Cadiz, Mental Health Inpatient Unit, General Hospital, Jerez de la Frontera, Spain; Serious Mental Disorder Research Group, Cadiz Biomedical Research and Innovation Institute, Spain; Department of Psychiatry, University of Cádiz, Cádiz, Spain.
  • Palacios-Garrán R; UGC North of Cadiz, Mental Health Inpatient Unit, General Hospital, Jerez de la Frontera, Spain; Serious Mental Disorder Research Group, Cadiz Biomedical Research and Innovation Institute, Spain.
  • Pérez-Revuelta JI; UGC North of Cadiz, Mental Health Inpatient Unit, General Hospital, Jerez de la Frontera, Spain; Serious Mental Disorder Research Group, Cadiz Biomedical Research and Innovation Institute, Spain; Department of Psychiatry, University of Cádiz, Cádiz, Spain.
Span J Psychiatry Ment Health ; 16(4): 266-267, 2023.
Article en En | MEDLINE | ID: mdl-38591738

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antipsicóticos / Clozapina Idioma: En Revista: Span J Psychiatry Ment Health Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antipsicóticos / Clozapina Idioma: En Revista: Span J Psychiatry Ment Health Año: 2023 Tipo del documento: Article